Dosimetric comparison of proton therapy and CyberKnife in stereotactic body radiation therapy for liver cancers

• Published in: Physical and engineering sciences in medicine 2024-09, Vol.47 (3), p.1203-1212
• Main Authors: Shyllon, Samuel, Penfold, Scott, Dalfsen, Ray, Kirkness, Elsebe, Hug, Ben, Rowshanfarzad, Pejman, Devlin, Peter, Tang, Colin, Le, Hien, Gorayski, Peter, Grogan, Garry, Kearvell, Rachel, Ebert, Martin A
• Format: Article
• Language: English
• Subjects: Biological and Medical Physics; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Biomedicine; Biophysics; Medical and Radiation Physics; Scientific Paper
• ISSN: 2662-4729; 2662-4737; 2662-4737
• DOI: 10.1007/s13246-024-01440-x

Stereotactic body radiation therapy (SBRT) has been increasingly used for the ablation of liver tumours. CyberKnife and proton beam therapy (PBT) are two advanced treatment technologies suitable to deliver SBRT with high dose conformity and steep dose gradients. However, there is very limited data comparing the dosimetric characteristics of CyberKnife to PBT for liver SBRT. PBT and CyberKnife plans were retrospectively generated using 4DCT datasets of ten patients who were previously treated for hepatocellular carcinoma (HCC, N  = 5) and liver metastasis ( N  = 5). Dose volume histogram data was assessed and compared against selected criteria; given a dose prescription of 54 Gy in 3 fractions for liver metastases and 45 Gy in 3 fractions for HCC, with previously published consensus-based normal tissue dose constraints. Comparison of evaluation parameters showed a statistically significant difference for target volume coverage and liver, lungs and spinal cord ( p